Skip to content

Guardant Health, Inc.

GH

CIK 0001576280 · Services-Medical Laboratories · Nasdaq

← back to feed
Revenue (TTM)
$1B
+32.9% YoY Q1 May 2026
Net Income (TTM)
−$399.86M
+4.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$3.16
+6.7% YoY Q1 May 2026
Gross Margin
64.6%
Q1 May 2026
Operating Margin
-43.7%
Q1 May 2026
Net Margin
-39.9%
Q1 May 2026
Free Cash Flow (TTM)
−$257.53M
Q1 May 2026
Cash
$989.29M
Q1 May 2026
Total Debt
$1.5B
Q1 May 2026
Shares Outstanding
132.6M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings